Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery

Pharmacology and Therapeutics

Volumn 112, Issue 3, 2006, Pages 630-648

  Nishiyama, Nobuhiro ^a,b   Kataoka, Kazunori ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cancer targeted therapy; Drug delivery; Gene and siRNA delivery; Nanotechnology; Photodynamic therapy; Polymeric micelles

Indexed keywords

4 PHENYL 1 BUTANOLATE; 6 [4 DEOXY 4 (2,4 TETRADECADIENOYLGLYCYLAMINO) GLYCERO BETA MANNOHEPTOPYRANOSYLAMINO] 9H PURINE; AMPHOTERICIN B; ANTIBODY; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BENZOPORPHYRIN DERIVATIVE; CISPLATIN; COPOLYMER; DOXORUBICIN; DRUG CARRIER; FATTY ACID DERIVATIVE; LIPOSOME; MACROGOL; NK 105; NK 911; OXALIPLATIN; PACLITAXEL; PEPTIDE; PHOTOSENSITIZING AGENT; PLASMID DNA; PLATINUM 1,2 DIAMINOCYCLOHEXANE MALONATE; POLOXAMER; POLYETHYLENEGLYCOL BLOCK POLY(ASPARTIC ACID); POLYETHYLENEIMINE; POLYMER; SMALL INTERFERING RNA; SPICAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AREA UNDER THE CURVE; BIOACCUMULATION; CANCER CHEMOTHERAPY; CARCINOMA; CHRONIC TOXICITY; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED DRUG RELEASE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG PENETRATION; DRUG POTENCY; DRUG SAFETY; DRUG STABILITY; DRUG TARGETING; GENE TARGETING; HAND FOOT SYNDROME; HUMAN; HYDROPHOBICITY; INJECTION SITE REACTION; KIDNEY TUMOR; LIVER TUMOR; MICELLE; NANOTECHNOLOGY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PARTICLE SIZE; PHARMACEUTICAL ENGINEERING; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SPLEEN TUMOR; SUSTAINED DRUG RELEASE;

ANIMALS; DENDRITIC CELLS; DNA; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; HUMANS; MICELLES; NANOPARTICLES; PHOTOCHEMOTHERAPY; PLASMIDS; POLYMERS; TISSUE DISTRIBUTION;

EID: 33750136313     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2006.05.006     Document Type: Review

References (134)

1. Allen T.M., and Hansen C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta 1068 (1991) 133-141
2. Allen C., Maysinger D., and Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B Biointerfaces 16 (1999) 3-27
3. Bae Y., Fukushima S., Harada A., and Kataoka K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew Chem Int Ed 42 (2003) 4640-4643
4. Bae Y., Nishiyama N., Fukushima S., Koyama H., Matsumura Y., and Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 16 (2005) 122-130
5. Bae Y., Jang W.-D., Nishiyama N., Fukushima S., and Kataoka K. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol Biosyst 1 (2005) 242-250
6. Batrakova E.V., Li S., Elmquist W.F., Miller D.W., Alakhov V.Y., and Kabanov A.V. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion. Br J Cancer 85 (2001) 1987-1997
7. Behr J.P. The proton sponge. A trick to enter cells the viruses did not exploit. Chimia 51 (1997) 34-36
8. Berg K., Selbo P.K., Prasmikaite L., Tjelle T.E., Sandvig K., Moan J., et al. Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. Cancer Res 59 (1999) 1180-1183
9. Boeckle S., von Gersdorff K., van der Piepen S., Culmsee C., Wagner E., and Ogris M. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J Gene Med 6 (2004) 1102-1111
10. Cabral H., Nishiyama N., Okazaki S., Koyama H., and Kataoka K. Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles. J Control Release 101 (2005) 223-232
11. Chau I., and Cunningham D. Oxaliplatin for colorectal cancer in the United States: better late than never. J Clin Oncol 21 (2003) 2049-2051
12. Clapham D.E. Calcium signaling. Cell 80 (1995) 259-268
13. Derycke A.S.L., and de White P.A.M. Liposomes for photodynamic therapy. Adv Drug Deliv Rev 56 (2004) 17-30
14. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., et al. Photodynamic therapy. J Natl Cancer Inst 90 (1998) 889-904
15. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2 (2003) 347-360
16. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 (1995) 1029-1039
17. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
18. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5 (2005) 161-171
19. Fukushima S., Miyata K., Nishiyama N., Kanayama N., Yamasaki Y., and Kataoka K. PEGylated polyplex micelles from triblock catiomers with spatially ordered layering of condensed pDNA and buffering units for enhanced intracellular gene delivery. J Am Chem Soc 127 (2005) 2810-2811
20. Gianasi E., Wasil M., Evagarou E.G., Keddle A., Wilson G., and Duncan D. HPMA copolymer platinates as novel antitumor agents: in vitro properties, pharmacokinetics and antitumor activity in vivo. Eur J Cancer 35 (1999) 994-1002
21. Gordon A.N., Fleagle J.T., Guthrie D., Parkin D.E., Gore M.E., and Lacave A.J. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin vs. topotecan. J Clin Oncol 19 (2001) 3312-3322
22. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
23. Grossweiner L.I., Patel A.S., and Grossweiner J.B. Type I and type II mechanisms in the photosensitized lysis of phosphatidylcholine liposomes by hematoporphyrin. Photochem Photobiol 36 (1982) 159-167
24. Hamaguchi T., Mastumura Y., Suzuki M., Shimizu K., Goda R., Nakamura I., et al. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumor activity and reduce the neurotoxicity of paclitaxel. Br J Cancer 92 (2005) 1240-1246
25. Hamilton G. Multicellular spheroids as an in vitro tumor model. Cancer Lett 131 (1998) 29-34
26. Harada A., and Kataoka K. Formation of polyion complex micelles in aqueous milieu from a pair of oppositely-charged block copolymers with poly(ethylene glycol) segments. Macromolecules 28 (1995) 5294-5299
27. Harada A., and Kataoka K. Chain length recognition: core-shell supermolecular assembly from oppositely charged block copolymers. Science 283 (1999) 65-67
28. Harada-Shiba M., Yamauchi K., Harada A., Takamisawa I., Shimokado K., and Kataoka K. Polyion complex micelles as vectors in gene therapy - pharmacokinetics and in vivo gene transfer. Gene Ther 9 (2002) 407-414
29. Hobbs S.K., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A 95 (1998) 4607-4612
30. Høgset A., Prasmickaite L., Tjelle T.E., and Berg K. Photochemical transfection: a new technology for light-induced, site-directed gene delivery. Hum Gene Ther 11 (2000) 869-880
31. Høgset A., Prasmickaite L., Hellum M., Engesæter B.Ø., Olsen V.M., Tjelle T.E., et al. Photochemical transfection: a technology for efficient light-directed gene delivery. Somat Cell Mol Genet 27 (2002) 97-113
32. Høgset A., Prasmickaite L., Selbo P.K., Hellum M., Engesæter B.Ø., Bondted A., et al. Photochemical internalization in drug and gene delivery. Adv Drug Deliv Rev 56 (2004) 95-115
33. Ideta R., Tasaka F., Jang W.-D., Nishiyama N., Zhang G.-D., Harada A., et al. Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer. Nano Lett 5 (2005) 2426-2431
34. Itaka K., Harada A., Nakamura K., Kawaguchi H., and Kataoka K. Evaluation by fluorescence resonance energy transfer of the stability of nonviral gene delivery vectors under physiological conditions. Biomacromolecules 3 (2002) 841-845
35. Itaka K., Yamauchi K., Harada A., Nakamura K., Kawaguchi H., and Kataoka K. Polyion complex micelles from plasmid DNA and poly(ethylene glycol)-poly(l-lysine) block copolymer as serum-tolerable polyplex system: physiological properties of micelles relevant to gene transfection efficiency. Biomaterials 24 (2003) 4495-4506
36. a directed to enhance intracellular gene silencing. J Am Chem Soc 126 (2004) 13612-13613
37. Jain R.K. Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 46 (2001) 149-168
38. Jang W.D., Nishiyama N., Zhang G.D., Harada A., Jiang D.L., Kawauchi S., et al. Supramolecular nanocarrier of anionic dendrimer porphyrins with cationic block copolymers modified with polyethylene glycol to enhance intracellular photodynamic efficacy. Angew Chem Int Ed 44 (2005) 419-423
39. Jeon S.I., Lee J.H., Andrade J.D., and De Gennes P.G. Protein-surface interactions in the presence of polyethylene oxide: I. Simplified theory. J Colloid Interface Sci 142 (1991) 149-158
40. Jeong Y.-I., Cheon J.-B., Kim S.-H., Nah J.-W., Lee Y.-M., Sung Y.-K., et al. Clonazepam release from core-shell type nanoparticles in vitro. J Control Release 51 (1998) 169-178
41. Kabanov A.V., Batrakova E.V., Sriadibhatla S., Yang Z., Kelly D.L., and Alakhov V.Y. Polymer genomics: shifting the gene and drug delivery paradigm. J Control Release 101 (2005) 259-271
42. Kakizawa Y., Harada A., and Kataoka K. Environment-sensitive stabilization of core-shell structured polyion complex micelle by reversible cross-linking of the core through disulfide bond. J Am Chem Soc 121 (1999) 11247-11248
43. Kakizawa Y., Miyata K., Furukawa S., and Kataoka K. Size-controlled formation of a calcium phosphate-based organic-inorganic hybrid vector for gene delivery using poly(ethylene glycol)-block-poly(aspartic acid). Adv Mater 16 (2004) 699-702
44. Kakizawa Y., Furukawa S., and Kataoka K. Block copolymer-coated calcium-phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery. J Control Release 97 (2004) 345-356
45. Kataoka K., Kwon G.S., Yokoyama M., Okano T., and Sakurai Y. Block copolymer micelles as vehicles for drug delivery. J Control Release 24 (1993) 119-132
46. Kataoka K. Targetable polymeric drugs (Chap. 4). In: Park K. (Ed). Controlled Drug Delivery: The Next Generation (1996), ACS, Washington, DC
47. Kataoka K., Togawa H., Harada A., Yasugi K., Matsumoto T., and Katayose S. Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline. Macromolecules 29 (1996) 8556-8557
48. Kataoka K., Harada A., and Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 47 (2001) 113-131
49. Katayama Y., Sonoda T., and Maeda M. A polymer micelle responding to the protein kinase A signal. Macromolecules 34 (2001) 8569-8573
50. Katayose S., and Kataoka K. Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-p(l-lysine) block copolymer. Bioconjug Chem 8 (1997) 702-707
51. Kohn S., Nagy J.A., Dvorak H.F., and Dvorak A.M. Pathways of macromolecular tracer transport across venules and small veins. Lab Invest 67 (1992) 596-607
52. Kohori F., Sakai K., Aoyagi T., Yokoyama M., Yamato M., Sakurai Y., et al. Control of adriamycin cytotoxic activity using thermally responsive polymeric micelles composed of poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(d,l-lactide ). Colloids Surf B Biointerfaces 16 (1999) 195-205
53. Konerding M.A., Fait E., and Gaumann A. 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon. Br J Cancer 84 (2001) 1354-1362
54. Kwon G.S., Suwa S., Yokoyama M., Okano T., Sakurai Y., and Kataoka K. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-Adriamycin conjugate. J Control Release 29 (1994) 17-23
55. La S.B., Okano T., and Kataoka K. Preparation and characterization of the micelle-forming polymeric drug: Indomethacin-incorporated poly(ethylene oxide)-poly(β-benzyl l-aspartate) block copolymer micelles. J Pharm Sci 85 (1996) 85-90
56. Lavasanifar A., Samuel J., and Kwon G.S. Micelles of poly(ethylene oxide)-block-poly(N-alkyl stearate l-aspartamide): synthetic analogues of lipoproteins for drug delivery. J Biomed Mater Res 52 (2000) 831-835
57. Lavasanifar A., Sanuel J., and Kwon G.S. Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 54 (2002) 169-190
58. Le Garrec D., Taillefer J., Van Lier J.E., Lenaerts V., and Leroux J.C. Optimizing pH-responsive polymeric micelles for drug delivery in a cancer photodynamic therapy model. J Drug Target 10 (2002) 429-437
59. Lukyanov A.N., Hartner W.C., and Torchilin V.P. Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits. J Control Release 4 (2004) 187-193
60. Lee E.S., Na K., and Bae Y.H. Polymeric micelle for tumor pH and folate-mediated targeting. J Control Release 91 (2003) 103-113
61. Lemieux P., Guerin G., Paradis G., Proulx R., Chistyakova L., Kabanov A., et al. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther 7 (2000) 986-991
62. Lewin M., Carlesso N., Tung C.-H., Tang X.W., Cory D., Scadden D.T., et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18 (2000) 410-414
63. Liu J., Zhang Q., Remsen E.E., and Wooley K.L. Nanostructured materials designed for cell binding and transduction. Biomacromolecules 2 (2001) 362-368
64. Macdonald I.J., and Dougherty T.J. Basic principle of photodynamic therapy. J Porphyr Phthalocyanines 5 (2001) 105-129
65. Maeda H. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv Drug Deliv Rev 46 (2001) 169-185
66. Maruyama K., Ishida O., Takizawa T., and Moribe K. Possibility of active targeting to tumor tissues with liposomes. Adv Drug Deliv Rev 40 (1999) 89-102
67. Matsumura Y., and Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs. Cancer Res 46 (1986) 6387-6392
68. Matsumura Y., Hamaguchi T., Ura T., Muro K., Yamada Y., Shimada Y., et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, micelle-encapsulated doxorubicin. Br J Cancer 91 (2004) 1775-1781
69. McKeage M.J. New-generation platinum drugs in the treatment of cisplatin-resistant cancers. Expert Opin Investig Drugs 14 (2005) 1033-1046
70. Merdan T., Callahan J., Peterson H., Kunath K., Bakowsky U., Kopeckova P., et al. Pegylated polyethylenimine-Fab′ antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjug Chem 14 (2003) 989-996
71. Minko T., Kopeckova P., and Kopecek J. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells. Pharm Res 16 (1999) 986-996
72. Minko T., Kopeckova P., and Kopecek J. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Int J Cancer 86 (2000) 108-117
73. Minko T., Batrakova E.V., Li S., Pakunlu R.I., Alakhov V.Y., and Kabanov A.V. Pluronic block copolymers alter apoptoric signal transduction of doxorubicin in drug-resistant cancer cells. J Control Release 105 (2005) 269-278
74. Miyamoto Y., and Maeda H. Comparison of the cytotoxic effects of the high-and low-molecular weight anticancer agents on multidrug-resistant Chinese hamster ovary cells in vitro. Cancer Res 50 (1990) 1571-1575
75. Miyata K., Kakizawa Y., Nishiyama N., Harada A., Yamasaki Y., Koyama H., et al. Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. J Am Chem Soc 126 (2004) 2355-2361
76. Miyata K., Kakizawa Y., Nishiyama N., Yamasaki Y., Watanabe T., Kohara M., et al. Practically applicable cross-linked polyplex micelle with high tolerability against freeze-drying for in vivo gene delivery. J Control Release 109 (2005) 15-23
77. Mosqueria V.C.F., Legrand P., Gulik A., Bourdon O., Gref R., Labarre D., et al. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanoparticles. Biomaterials 22 (2001) 2967-2979
78. Muggia F.M. Liposomal encapsulated anthracyclines: new therapeutic horizons. Curr Oncol Rep 3 (2001) 156-162
79. Muggia F.M., Hamsworth J.L., Jeffers S., Miller P., Groshen S., Tan M., et al. Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J Clin Oncol 15 (1996) 987-993
80. Nagasaki Y., Yasugi K., Yamamoto Y., Harada A., and Kataoka K. Sugar-installed block copolymer micelles: their preparation and specific interaction with lectin molecules. Biomacromolecules 2 (2001) 1067-1070
81. Nah J.-W., Yu L., Han S.-O., Ahn C.-H., and Kim S.W. Artery wall binding peptide-poly(ethylene glycol)-grafted-poly(l-lysine)-based gene delivery to artery wall cells. J Control Release 78 (2002) 273-284
82. Neal C.R., and Michel C.C. Transcellular gaps in microvascular walls of frog and rat when permeability is increased by perfusion with the ionophore. J Physiol 488 (1995) 427-437
83. Newman M.S., Colbern G.T., Working P.K., Engbers C., and Amantea M.A. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. Cancer Chemother Pharmacol 43 (1999) 1-7
84. Nishiyama N., and Kataoka K. Nanostructured devices based on block copolymer assemblies for drug delivery: designing structures for enhanced drug function. Adv Polym Sci 193 (2006) 67-101
85. Nishiyama N., Yokoyama M., Aoyagi T., Okano T., Sakurai Y., and Kataoka K. Preparation and characterization of self-assembled polymer-metal complex micelle from cis-dichlorodiammineplatinum(II) and poly(ethylene glycol)-poly(aspartic acid) block copolymer in an aqueous medium. Langmuir 15 (1999) 377-383
86. Nishiyama N., Kato Y., Sugiyama Y., and Kataoka K. Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system. Pharm Res 18 (2001) 1035-1041
87. Nishiyama N., Stapert H.R., Zhang G.D., Takasu D., Jiang D.-L., Nagano T., et al. Light-harvesting ionic dendrimer porphyrins as new photosensitizers for photodynamic therapy. Bioconjug Chem 14 (2003) 58-66
88. Nishiyama N., Koizumi F., Okazaki S., Matsumura Y., Nishio K., and Kataoka K. Differential gene expression profile between PC-14 cells treated with free cisplatin- and cisplatin-incorporated polymeric micelles. Bioconjug Chem 14 (2003) 449-457
89. Nishiyama N., Nori A., Malugin A., Kasuya Y., Kopecková P., and Kopecek J. Free and N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-bound geldanamycin derivative induce different stress responses in A2780 human ovarian carcinoma cells. Cancer Res 63 (2003) 7876-7882
90. Nishiyama N., Okazaki S., Cabral H., Miyamoto M., Kato Y., Sugiyama Y., et al. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res 63 (2003) 8977-8983
91. Nishiyama N., Iiyama A., Jang W.-D., Miyata K., Itaka K., Inoue Y., et al. Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer. Nat Mater 4 (2005) 934-941
92. Nishiyama N., Bae Y., Miyata K., Fukushima S., and Kataoka K. Smart polymeric micelles for gene and drug delivery. Drug Discov Today Technol 2 (2005) 21-26
93. Oishi M., Nagasaki Y., Itaka K., Nishiyama N., and Kataoka K. Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile β-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J Am Chem Soc 127 (2005) 1624-1625
94. Omelyanenko V., Kopeckova P., Gentry C., and Kopecek J. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J Control Release 53 (1998) 25-37
95. Pack D.W., Hoffman A., Pun S., and Stayton P.S. Design and development of polymers for gene delivery. Nat Rev Drug Discov 4 (2005) 581-593
96. Prasmickaite L., Høgset A., and Berg K. Evaluation of different photosensitizers for use in photochemical gene transfection. Photochem Photobiol 73 (2001) 388-395
97. Renno R.Z., and Miller J.W. Photosensitizer delivery for photodynamic therapy of choroidal neovascularization. Adv Drug Deliv Rev 52 (2001) 63-78
98. Roberts W.G., and Palade G.E. Neovascular induced by vascular endothelial growth factor is fenestrated. Cancer Res 57 (1997) 765-772
99. Rosenberg B. Platinum complexes for the treatment of cancer. Interdisc Sci Rev 3 (1978) 134-147
100. Rudolph C., Plank C., Lausier J., Schillinger U., Muller R.H., and Rosenecker J. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem 278 (2003) 11411-11418
101. Savic R., Luo L., Eisenberg A., and Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300 (2003) 615-618
102. Seymour L.W., Duncan R., Strohalm J., and Kopecek J. Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J Biomed Mater Res 21 (1987) 1341-1358
103. Sheff D. Endosomes as a route for drug delivery in the real world. Adv Drug Deliv Rev 56 (2004) 927-930
104. Siddik Z.H., Newell D.R., Boxall F.E., and Harrap K.R. The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats. Biochem Pharmacol 36 (1987) 1925-1932
105. Stapert H.R., Nishiyama N., Jiang D.-L., Aida T., and Kataoka K. Polyion complex micelles encapsulating light-harvesting ionic dendirmer zinc porphyrins. Langmuir 16 (2000) 8182-8188
106. Stewart S., Jablonowski H., Goebel F.D., Arasteh K., Spittle M., Rios A., et al. Randomized comparative trial of pegylated liposomal doxorubicin vs. bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group. J Clin Oncol 16 (1998) 683-691
107. Stolnik S., Illum L., and Davis S.S. Long circulating microparticulate drug carriers. Adv Drug Deliv Rev 16 (1995) 195-214
108. Sutherland R.M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240 (1988) 177-184
109. TAP and VIP Study Group. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 22 (2002) 6-18
110. Tijerina M., Kopeckova P., and Kopecek J. Mechanism of cyototoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer Mce6 conjugates. Photochem Photobiol 77 (2003) 645-652
111. Torchilin V.P. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliv Rev 54 (2002) 235-252
112. Torchilin V.P., Lukyanov A.N., Gao Z., and Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci U S A 100 (2003) 6039-6044
113. Tsukioka Y., Matsumura Y., Hamaguchi T., Koike H., Moriyasu F., and Kakizoe T. Pharmaceutical and biomedical differences between micellar doxorubicin (NK911) and liposomal doxorubicin (Doxil). Jpn J Cancer Res 93 (2002) 1145-1153
114. Uchino H., Matsumura Y., Negishi T., Koizumi F., Hayashi T., Honda T., et al. Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats. Br J Cancer 93 (2005) 678-687
115. Unezaki S., Maruyama K., Hosoda J., Nagai I., Koyanagi Y., Nakata M., et al. Direct measurement of the extravasation of polyethylene glycol-coated liposomes into solid tumour tissue by in vivo fluorescence microscopy. Int J Pharmacol 144 (1996) 11-17
116. Uwatoku T., Shimokawa H., Abe K., Matsumoto Y., Hattori T., Oi K., et al. Application of nanoparticle technology for the prevention of restenosis after balloon injury in rats. Circ Res 92 (2003) e62-e69
117. Uziely B., Jeffers S., Isacson R., Kutsch K., Wei-Taso D., Yehoshua Z., et al. Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J Clin Oncol 13 (1995) 1777-1785
118. Verma I.M., and Somia N. Gene therapy-promises, problems and prospects. Nature 389 (1997) 239-242
119. Vinogradov S., Batrakova E., Li S., and Kabanov A. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. Bioconjug Chem 10 (1999) 851-860
120. Ward C.M., Read M.L., and Seymour L.W. Systemic circulation of poly(l-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood 97 (2001) 2221-2229
121. Wakebayashi D., Nishiyama N., Yamasaki Y., Itaka K., Kanayama N., Harada A., et al. Lactose-conjugated polyion complex micelles incorporating plasmid DNA as a targetable gene vector system: their preparation and gene transfecting efficiency against cultured HepG2 cells. J Control Release 95 (2004) 653-664
122. Weitman S.D., Lark R.H., Coney L.R., Fort D.W., Frasca V., Zurawski Jr. V.R., et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52 (1992) 3396-3401
123. Woodle M.C., Matthay K.K., Newman M.S., Hidayat J.E., Collins L.R., Redemann C., et al. Versatility in lipid composition showing prolonged circulation with sterically stabilized liposome. Biochim Biophys Acta 1105 (1992) 193-200
124. Yamamoto Y., Nagasaki Y., Kato Y., Sugiyama Y., and Kataoka K. Long-circulating poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles with modulated surface charge. J Control Release 77 (2001) 27-38
125. Yamamoto Y., Yasugi K., Harada A., Nagasaki Y., and Kataoka K. Temperature-related change in the properties relevant to drug delivery of poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles in aqueous milieu. J Control Release 82 (2002) 359-371
126. Yokoyama M., Inoue S., Kataoka K., Yui N., Okano T., and Sakurai Y. Molecular design for missile drugs: synthesis of adriamycin conjugated with immunoglobulin G using poly(ethylene glycol)-block-poly(aspartic acid) as intermediate carrier. Makromol Chem 190 (1989) 2041-2054
127. Yokoyama M., Miyauchi M., Yamada N., Okano T., Kataoka K., and Inoue S. Polymer micelles as novel drug carriers: adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. J Control Release 11 (1990) 269-278
128. Yokoyama M., Miyauchi M., Yamada N., Okano T., Sakurai Y., Kataoka K., et al. Characterization and anti-cancer activity of micelle-forming polymeric anti-cancer drug, adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res 50 (1990) 1693-1700
129. Yokoyama M., Okano T., Sakurai Y., Ekimoto H., Shibazaki C., and Kataoka K. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res 51 (1991) 3229-3236
130. Yokoyama M., Sugiyama T., Okano T., Sakurai Y., Naito M., and Kataoka K. Analysis of micelle formation of an adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography. Pharm Res 10 (1993) 895-899
131. Yokoyama M., Okano T., Sakurai Y., and Kataoka K. Improved synthesis of adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin. J Control Release 32 (1994) 269-277
132. Yokoyama M., Satoh A., Sakurai Y., Okano T., Matsumura Y., Kakizoe T., et al. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Control Release 55 (1998) 219-229
133. Yokoyama M., Okano T., Sakurai Y., Fukushima S., Okamoto K., and Kataoka K. Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J Drug Target 7 (1999) 171-186
134. Yuan F., Chen Y., Dellian M., Safabakhsh N., Ferrara N., and Jain R.K. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci U S A 93 (1996) 14765-14770